April 15 (Reuters) - Bioton SA BIOP.WA :
* REPORTED ON TUESDAY FY NET LOSS OF 126.7 MILLION ZLOTYS
VERSUS
PROFIT OF 26.3 MILLION ZLOTYS YEAR AGO
* FY REVENUE 202.0 MILLION ZLOTYS VERSUS 241.2 MILLION
ZLOTYS YEAR
AGO
* ON CORONAVIRUS: TRIES TO SECURE PRODUCTION BY INCREASING
SUPPLY
OF KEY RAW MATERIALS FOR 6 MONTHS IN ADVANCE, WHICH MAY BE
DIFFICULT AS THE COMPANY'S SUPPLIERS WILL SOON BE AT THE VERGE
OF THEIR PRODUCTION CAPACITY
* SECURING PRODUCTS ON THE POLISH MARKET AND PROBLEMS WITH
SHIPMENT OF PRODUCTS TO FOREIGN MARKETS MAY CAUSE PROBLEMS WITH
COLLECTION OF FOREIGN RECEIVABLES
* TO SECURE ITS LIQUIDITY, THE COMPANY HAS SIGNED ANNEXES TO
LOAN
DEALS WITH BANK OCHRONY SRODOWISKA AND HSBC CHANGING CAPITAL
REPAYMENT SCHEDULES AND IS IN TALKS WITH BANK OF CHINA TO
MAXIMIZE THE LEVEL OF AVAILABLE CASH IN THE NEAR FUTURE
* SEES NO RISK TO SALES OF INSULIN AS IT IS A LIVE-SAVING
MEDICINE
AND MUST BE TAKEN REGARDLESS OF CIRCUMSTANCES RELATED TO
COVID-19 PANDEMIC
Source text for Eikon: urn:newsml:reuters.com:*:nEM4cDdZsa
Further company coverage: BIOP.WA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10))